Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol or Metoprolol in Arterial Occlusive Disease
ISRCTN06278310Phase 3Completed
- Sponsor
- Berlin-Chemie AG
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in peripheral artery occlusion (PAD) and hypertension (HTN) comparing Nebilet with Metoprolol (2 arms). Primary endpoint: Flow-mediated dilation. Started Feb 2006; status: completed.
02
Drugs
nebivololmetoprolol
03
Conditions
peripheral artery occlusion (PAD)hypertension (HTN)
Beyond the preview
Go deeper on ISRCTN06278310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN06278310.